Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
HGAS - Global Gas Corp - Stock Price Chart
TickerHGAS [NASD]
CompanyGlobal Gas Corp
CountryUSA
IndustrySpecialty Chemicals
Market Cap11.22MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-108.78%
Dividend-Sales Q/Q-
Insider Own86.27%Inst Own8.17%
Insider Trans0.00%Inst Trans37.70%
Short Float3.19%Earnings-
Analyst Recom-Target Price-
Avg Volume93.76K52W Range1.05 - 10.66
Global Gas Corporation engages in the development and supply of nascent pure-play hydrogen, carbon and industrial gas. The company was Founded in 1989 and is headquartered in New York, NY.
RNAC - Cartesian Therapeutics Inc - Stock Price Chart
TickerRNAC [NASD, RUT]
CompanyCartesian Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap478.64MEPS (ttm)-56.02
P/E-EPS this Y82.05%
Forward P/E-EPS next Y32.14%
PEG-EPS past 5Y10.69%
P/S18.47EPS next 5Y-
P/B-EPS Q/Q-147.65%
Dividend-Sales Q/Q-1.65%
Insider Own27.74%Inst Own10.63%
Insider Trans32.93%Inst Trans74.34%
Short Float6.10%EarningsMay 08/b
Analyst Recom1.00Target Price56.25
Avg Volume67.88K52W Range11.66 - 42.60
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPRINGER TIMOTHY ADirectorMar 26 '24Option Exercise1.461,970,4432,876,84733,043,849Mar 26 04:32 PM
SPRINGER TIMOTHY ADirectorMar 18 '24Buy0.6019,04411,39831,073,406Mar 20 05:09 PM
SPRINGER TIMOTHY ADirectorMar 18 '24Buy0.61800488104,818Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 15 '24Buy0.59537,500314,54531,054,362Mar 18 05:29 PM
SPRINGER TIMOTHY ADirectorMar 15 '24Buy0.561,200672104,018Mar 28 05:11 PM
KPLT - Katapult Holdings Inc - Stock Price Chart
TickerKPLT [NASD]
CompanyKatapult Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap77.75MEPS (ttm)-9.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-39.02%
P/S0.35EPS next 5Y-
P/B-EPS Q/Q-21.66%
Dividend-Sales Q/Q16.10%
Insider Own46.11%Inst Own18.74%
Insider Trans-0.00%Inst Trans-45.80%
Short Float3.49%EarningsMay 15/b
Analyst Recom3.00Target Price16.00
Avg Volume12.76K52W Range8.26 - 24.76
Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zayas OrlandoChief Executive OfficerFeb 15 '24Option Exercise0.009190129,832Feb 21 05:20 PM
TOWERS CHRISTOPHERChief Accounting OfficerFeb 15 '24Option Exercise0.00197011,334Feb 21 05:17 PM
Medlin DerekChief Operating OfficerFeb 15 '24Option Exercise0.00276049,709Feb 21 05:14 PM
Chopra ChandanChief Technology OfficerFeb 15 '24Option Exercise0.00786022,473Feb 21 05:11 PM
Zayas OrlandoChief Executive OfficerNov 29 '23Sale12.58563128,913Dec 01 04:34 PM
ALT - Altimmune Inc - Stock Price Chart
TickerALT [NASD, RUT]
CompanyAltimmune Inc
CountryUSA
IndustryBiotechnology
Market Cap601.86MEPS (ttm)-1.59
P/E-EPS this Y7.32%
Forward P/E-EPS next Y-1.28%
PEG-EPS past 5Y35.74%
P/S1467.94EPS next 5Y-
P/B3.48EPS Q/Q13.98%
Dividend-Sales Q/Q-76.19%
Insider Own8.81%Inst Own64.26%
Insider Trans0.00%Inst Trans10.67%
Short Float34.50%EarningsMay 09/b
Analyst Recom1.50Target Price20.57
Avg Volume4.33M52W Range2.09 - 14.84
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts M ScotChief Scientific OfficerFeb 02 '24Option Exercise0.007,775044,990Feb 05 06:02 PM
Harris Matthew ScottChief Medical OfficerFeb 02 '24Option Exercise0.007,775055,965Feb 05 06:01 PM
Garg Vipin KPresident and CEOFeb 02 '24Option Exercise0.0018,9500300,404Feb 05 06:00 PM
Harris Matthew ScottChief Medical OfficerFeb 01 '24Option Exercise0.006,166049,991Feb 05 06:01 PM
Roberts M ScotChief Scientific OfficerFeb 01 '24Option Exercise0.006,166039,016Feb 05 06:02 PM
POCI - Precision Optics Corp., Inc. - Stock Price Chart
TickerPOCI [NASD]
CompanyPrecision Optics Corp., Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap40.37MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y26.64%
P/S2.10EPS next 5Y-
P/B3.57EPS Q/Q-217.03%
Dividend-Sales Q/Q-18.05%
Insider Own38.88%Inst Own14.21%
Insider Trans0.00%Inst Trans-
Short Float0.15%EarningsMay 15/a
Analyst Recom-Target Price-
Avg Volume6.85K52W Range5.12 - 6.99
May-09-24 09:00AM Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program (GlobeNewswire) +6.37%
May-08-24 04:15PM Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024 (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 09:00AM Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company (GlobeNewswire)
Apr-23-24 04:15PM Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 (GlobeNewswire)
Apr-18-24 09:00AM Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application (GlobeNewswire)
Feb-15-24 10:39AM Precision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2024 Earnings Call Transcript (Insider Monkey)
Feb-14-24 04:30PM Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results (PR Newswire)
Feb-08-24 04:15PM Precision Optics Corporation Schedules Second Quarter of Fiscal Year 2024 Conference Call for Wednesday, February 14, 2024 (PR Newswire)
Jan-23-24 04:30PM Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024 (PR Newswire)
Precision Optics Corp. engages in the design, development, manufacture, and selling of optical instruments. Its products include microprecision lenses and micro medical cameras, 3D endoscopes, and robotic surgery systems. The company was founded by Richard E. Forkey in December 1982 and is headquartered in Gardner, MA.
DLPN - Dolphin Entertainment Inc. - Stock Price Chart
TickerDLPN [NASD]
CompanyDolphin Entertainment Inc.
CountryUSA
IndustryAdvertising Agencies
Market Cap22.76MEPS (ttm)-1.48
P/E-EPS this Y87.57%
Forward P/E5.08EPS next Y214.29%
PEG-EPS past 5Y-8.20%
P/S0.47EPS next 5Y-
P/B1.12EPS Q/Q92.46%
Dividend-Sales Q/Q54.03%
Insider Own8.32%Inst Own8.72%
Insider Trans1.89%Inst Trans11.60%
Short Float0.01%EarningsMay 14/a
Analyst Recom1.00Target Price6.00
Avg Volume66.03K52W Range0.95 - 2.48
Dolphin Entertainment, Inc. engages in the provision of entertainment marketing and content development. It operates through the following segments: Entertainment Publicity and Marketing, and Content Production. The Entertainment Publicity and Marketing segment consists of 42West, The Door, Viewpoint, and Shore Fire Media. The Content Production segment consists of Dolphin Entertainment and Dolphin Films. The company was founded on March 7, 1995 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Dowd William IVChief Executive OfficerDec 05 '23Buy1.604,8007,680142,186Dec 05 02:12 PM
O'Dowd William IVChief Executive OfficerDec 04 '23Buy1.634,0006,528137,386Dec 04 08:31 PM
O'Dowd William IVChief Executive OfficerNov 30 '23Buy1.7120,00034,180133,386Dec 01 12:10 PM
Famadas NelsonDirectorMay 18 '23Buy2.091,0002,0901,534May 18 04:01 PM
GALT - Galectin Therapeutics Inc - Stock Price Chart
TickerGALT [NASD]
CompanyGalectin Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap190.65MEPS (ttm)-0.75
P/E-EPS this Y10.81%
Forward P/E-EPS next Y-140.91%
PEG-EPS past 5Y-14.30%
P/S-EPS next 5Y-
P/B-EPS Q/Q9.67%
Dividend-Sales Q/Q-
Insider Own31.42%Inst Own12.52%
Insider Trans-0.10%Inst Trans-1.46%
Short Float7.35%EarningsMay 15/b
Analyst Recom1.00Target Price11.00
Avg Volume182.22K52W Range1.28 - 4.27
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zordani Richard A. Jr.DirectorApr 30 '24Buy3.521,0003,5201,000Apr 30 02:14 PM
LEWIS JOELPresident and CEOApr 24 '24Buy3.391,0003,3902,000Apr 25 01:27 PM
CZIRR JAMES C10% OwnerApr 23 '24Sale3.063,67711,2525,922,207Apr 25 11:36 AM
FREEMAN KEVIN DDirectorApr 22 '24Buy2.982,5007,45025,969Apr 22 04:04 PM
CZIRR JAMES C10% OwnerApr 22 '24Sale3.0621,32365,2485,925,884Apr 25 11:36 AM
JMIA - Jumia Technologies Ag ADR - Stock Price Chart
TickerJMIA [NYSE]
CompanyJumia Technologies Ag ADR
CountryGermany
IndustryInternet Retail
Market Cap664.49MEPS (ttm)-1.12
P/E-EPS this Y66.00%
Forward P/E-EPS next Y47.06%
PEG-EPS past 5Y16.58%
P/S3.29EPS next 5Y-
P/B15.45EPS Q/Q-27.30%
Dividend-Sales Q/Q5.67%
Insider Own0.35%Inst Own15.94%
Insider Trans0.00%Inst Trans11.49%
Short Float7.71%EarningsMay 07/b
Analyst Recom3.00Target Price4.00
Avg Volume3.99M52W Range2.22 - 8.10
Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.
WORX - SCWorx Corp - Stock Price Chart
TickerWORX [NASD]
CompanySCWorx Corp
CountryUSA
IndustryHealth Information Services
Market Cap2.79MEPS (ttm)-1.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.68%
P/S0.71EPS next 5Y-
P/B0.45EPS Q/Q-53.45%
Dividend-Sales Q/Q-8.19%
Insider Own9.05%Inst Own2.66%
Insider Trans0.00%Inst Trans-36.23%
Short Float3.44%Earnings-
Analyst Recom-Target Price-
Avg Volume2.28M52W Range1.14 - 14.40
SCWorx Corp. engages in the development of software for healthcare providers. It provides data normalization, application interoperability, and big data analytics. The company was founded by Marc S. Schessel in 2012 and is headquartered in New York, NY.
IMMX - Immix Biopharma Inc - Stock Price Chart
TickerIMMX [NASD]
CompanyImmix Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap62.86MEPS (ttm)-0.95
P/E-EPS this Y-24.00%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-63.30%
P/S-EPS next 5Y-
P/B2.25EPS Q/Q-25.78%
Dividend-Sales Q/Q-
Insider Own47.54%Inst Own12.45%
Insider Trans0.52%Inst Trans19.80%
Short Float2.80%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume180.96K52W Range1.40 - 7.75
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris Gabriel SCFOMay 14 '24Buy2.234,50010,04285,816May 14 09:29 PM
Rachman Ilya MCEO and ChairmanMay 14 '24Buy2.254,3009,660912,000May 14 09:28 PM
Hsu JasonDirectorDec 11 '23Buy4.6731,000144,894813,000Dec 12 06:25 PM
Hsu JasonDirectorDec 08 '23Buy4.8825,000122,025782,000Dec 12 06:25 PM
Hsu JasonDirectorSep 15 '23Buy2.497,00017,396757,000Sep 18 07:03 PM
15678910111213141520